Technological innovation in life sciences, paradigm shift or fad?

The healthcare industry has historically been reticent to disruptive changes brought about by exponential technologies. This scenario is common in highly regulated sectors or sectors with a high weight of the professional experience of their workers.
Technological innovation has a strategic cycle in which we are already immersed, and we must contribute to its development. In the field of health, it has acquired a growing role in the current social and political situation; being a fundamental tool to face the social, economic, and environmental challenges that we face.
The advice of professionals in the sector is essential for entrepreneurs, increasing the scientific legitimacy of their projects and improving access to finance.
The possibility of acquiring new knowledge, the challenge of developing new solutions, finding new motivations beyond clinical practice, helping technological disruption go the right way, social prestige by developing actions with real impact … are some of the motivations declared by health professionals who participate in these activities. Together with all this, the growing figure of the entrepreneur / investor healthcare professional is emerging.

The universe of participants in the process of financing companies in the initial stages of development has increased enormously in recent years in a scenario known as “Informal Venture Capital” but with a high degree of professionalization and rigor that is increasing from Progressive form.

The healthcare industry has historically been reticent to disruptive changes brought about by exponential technologies. This scenario is common in highly regulated sectors or sectors with a high weight of the professional experience of their workers.

Technological innovation has a strategic cycle in which we are already immersed, and we must contribute to its development. In the field of health, it has acquired a growing role in the current social and political situation; being a fundamental tool to face the social, economic and environmental challenges that we face.

Investor motivations
The possibility of acquiring new knowledge, the challenge of developing new solutions, finding new motivations beyond clinical practice, helping technological disruption go the right way, social prestige by developing actions with real impact … are some of the motivations declared by health professionals who participate in these activities. Together with all this, the growing figure of the entrepreneur / investor healthcare professional is emerging.

The possibility of acquiring new knowledge, the challenge of developing new solutions, finding new motivations beyond clinical practice, helping technological disruption go the right way, social prestige by developing actions with real impact … are some of the motivations declared by health professionals who participate in these activities. Together with all this, the growing figure of the entrepreneur / investor healthcare professional is emerging.

According to the latest report published by AEBAN (Spanish Association of Business Angels), most investors are in the age group between 35 and 54 with an active profile in the sector, with investment capacity of up to one hundred thousand euros and with networks of Business Angels as the main source of investment identification.

Aware of the high risk of their investments, 68% dedicate less than 10% of their total assets to this activity, being the segment between 25,000 and 50,000 euros where the most important segment relative to investment capacity is concentrated.

Investing in companies in the early stages of development is a purely social activity. In 93% of cases, joint investment strategies are produced with other similar investors, reaching in our country 20% of the investment volume of these characteristics in the life sciences and technology sector, with the incorporation of investors being key to growth with high experience in the sector to expand and improve the spectrum and quality of investments.